下一级精准医学:为什么治疗学方法是未来的未来
Aniello Iacomino1, Marco Rapa2, Gianluca Gatta2
1Guglielmo Marconi University of Rome, Rome, Italy.
概括
疗法学,结合诊断和治疗应用,为瘤学提供精准医学. 未来的进展包括针对癌症向治疗的放射性免疫结合物.
科学领域:
- 在瘤学瘤学.
- 精准医学是一门精准的医学.
- 放射性药物 放射性药物 放射性药物
背景情况:
- 治疗诊断学是精准医学中快速发展的领域,具有显著的瘤学潜力.
- 选择性放射性药物用于诊断和治疗目的,特别是在神经内分泌瘤和转移性割抵抗性前列腺癌 (mCRPC) 中.
研究的目的:
- 探索治疗诊断在瘤学的创新领域.
- 突出放射性药物和放射性免疫结合剂在癌症治疗中的当前和未来应用.
主要方法:
- 使用索马托斯塔丁受体激动剂治疗神经内分泌瘤.
- 在mCRPC中使用基于PSMA的.
- 探索用于诊断成像 (免疫-PET) 和治疗性放射性免疫疗法的放射性免疫结合物.
主要成果:
- 个性化受体放射性核素疗法 (PRRT) 在特定癌症中显示出有效性.
- 放射性免疫结合物代表了增强诊断和治疗能力的有希望的进化.
- 治疗术有助于更深入地了解瘤生物学,并开发有针对性的疗法.
结论:
- 诊断术对于推进精确瘤学的发展至关重要.
- 将治疗术纳入"奥米克时代"支持多学科,量身定制的癌症治疗方法.
- 放射性药物和放射性免疫结合物的持续创新将推动向癌症治疗的未来.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K


